The Centre for Translational and Interdisciplinary Research aims to:
- translate basic research in life sciences into clinical use through early-stage drug discovery and partnership with industry
- provide state-of-the-art and accessible research infrastructure to communities of academics and small- and medium-sized enterprises
- foster new areas of interdisciplinary activity
- develop mutually beneficial partnerships with key funding agencies and industry.
Funding for the Centre will be used to support key changes in infrastructure. It will create and equip a 5197 m2 addition to the College of Life Sciences and refurbish 485 m2 of adjacent space.
- double the size and capacity of the university’s Drug Discovery Unit, which adds considerable value to bioscience discoveries through small molecule drug discovery
- juxtapose mathematical biology, theoretical physics, bioinformatics, data analysis and software development, to generate innovative thinking and tackle systems-level problems relating to biology, drug discovery and scientific processes for storing and retrieving medical information
- create a Centre for Quantitative Proteomics, integrating expertise in cell biology, mass spectrometry, proteomics, ‘big-data’ analytics and computer science, to exploit the potential of the human genome project for healthcare and the development of safer drugs
- create an in-house biotech spin-out ‘pre-incubator’, where fledgling spin-out companies can be nurtured before reaching critical mass and spinning-out completely.
Read the blog 'Tearing down walls to build the future' on how UKRPIF funding has helped the Discovery Centre flourish.
Page last updated 20 September 2017